Business Standard

Friday, December 20, 2024 | 04:39 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

SEBI asks pharma companies to disclose details that can impact stock prices

The details that need to be disclosed are new drugs, pending patents, source of raw materials, and new partnerships, among others

pharma
Premium

BS Web Team New Delhi
The Securities Exchange Board of India (Sebi) has asked several pharma companies to submit the details on the public disclosures that influence the stock prices. This comes as several pharma stocks have seen sharp movements and Sebi wants to check if all the price-sensitive information was timely provided to the investors or not, according to a report by Economic Times (ET)

The details that need to be disclosed are new drugs, pending patents, source of raw materials, and new partnerships, among others. In several cases, SEBI has reportedly found that no disclosures were made at all. 

"In one case, the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in